Importantly, these findings were further validated at protein level by IHC analysis performed on the available patient-derived GB and peritumoral tissue samples, confirming the elevated expression of MEX3A in tumor tissues, and its diagnostic and prognostic potential in GB (Supplementary Figure S3). The gene discussed is MEX3A; the disease is neoplasm.